Vaxcyte Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Vaxcyte Inc. Common Stock and Dr. Reddy's Laboratories Ltd Common Stock are close in size by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| PCVX | RDY | |
|---|---|---|
Market Cap | $10.51B | $10.78B |
Volume | 2,644,694 | 2,724,343 |
Sector | Health | Health |
52-Week High | $73.82 | $15.38 |
52-Week Low | $40.32 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $10.68B |
Dividend Yield | — | 0.65% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →